Skip to content

MSH2 CM219AK

by Biocare Medical, LLC

Ref CM219AK

MSH2 CM219AK is a MSH2 antigen IVD (EU IVDD general IVD; FDA Class I; FDA product code NJT, Immunohistochemistry Reagents And Kits) made by Biocare Medical, LLC, registered in EUDAMED on 23 Sep 2026 (Basic UDI-DI B-00847627037657) and listed in FDA GUDID since 23 Sep 2022 (UDI-DI 00847627037657), active as of 23 Oct 2026.

Active European Union. Also listed in GUDID (US).

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-00847627037657 Basic UDI-DI 00847627037657UDI-DIDate23 Sep 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00847627037657 UDI-DI Date23 Sep 2022ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI B-00847627037657 registered 23 Sep 2026 Active
  • FDA GUDID UDI-DI 00847627037657 listed 23 Sep 2022 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 00847627037657
  2. Registered EUDAMED B-00847627037657

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
MSH2
Generic name
MSH2 antigen IVD, antibody
Model / reference
CM219AK
Primary DI / UDI-DI
00847627037657 EUDAMED
00847627006837 GUDID
Basic UDI-DI
B-00847627037657
FDA product code
NJT
EMDN code
W01060214 Colorectal cancer (msi-h / dmmr)
GMDN term
MSH2 antigen IVD, antibody
Device class
Class IVD General EUDAMED
Class I GUDID
Regulation number
864.1860
EU registration type
Legacy device (under a directive)
EU market of registration
Türkiye
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 2 fields differ

FieldEUDAMEDGUDID
Primary DI / UDI-DIEUDAMED
00847627037657
GUDID
00847627006837
Device classEUDAMED
Class IVD General
GUDID
Class I

The registries describe this device under different primary UDI-DIs (EUDAMED lists 00847627037657; FDA GUDID lists 00847627006837), so their flags are not compared. Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under COLORECTAL CANCER (MSI-H / DMMR).

Other devices from Biocare Medical, LLC

See all devices from Biocare Medical, LLC →

Properties

  • Contains animal tissues or cells
  • Reagent
  • Professional testing
  • Prescription use
  • Convenience kit
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (17, all answered No)